The Effect of Infection with some Intestinal Parasites on some Immune Parameters
Main Article Content
Abstract
275 fecal samples were collected from visitors to Tikrit Teaching Hospital and some private laboratories in Tikrit city/Salah al-Din Governorate. The collection period lasted from December 2022 until April 2023. The study included examining samples of both males and females of different ages.
The study showed a significant decrease in level of IgG among people infected with Entamoeba histolytica by 92.00 ± 19.1, as well as for people infected with Giardia lamblia, as a significant decrease was recorded by 76.43 ± 15.1 compared to healthy people by a percentage of 130.60 ± 29.5.
No significant difference was recorded between people infected with E.histolytica in level of IgM, as the percentage reached 83.4 ± 13.6. Likewise, for people infected with G.lamblia, no significant difference was recorded, as the percentage was (106.0 ± 21.7) compared to healthy people, as the percentage reached ( 84.6 ± 18.0. ).
There was a significant decrease in the level of the CD4 differentiation complex among people infected with E. histolytica by a rate of 160.8 ± 23.9. Likewise, for people infected with G. lamblia, a significant decrease was recorded, reaching a rate of 187.5 ± 31.8 compared to healthy people by a rate of 475.2 ± 28.1.
A significant decrease was recorded among people infected with E. histolytica in the level of CD8 differentiation complex, as the percentage reached 9.00 ± 2.51. Likewise, for people infected with G. lamblia , a significant decrease was recorded by 10.18 ± 2.60 compared to healthy people, with a percentage of 14.50 ± 3.40.
There was a significant decrease in the level of IL6 in people infected with E. histolytica, as the percentage reached 85.02 ± 13.20, while in people infected with G. lamblia, no significant difference was recorded, as the percentage reached 196.30 ± 17.10, compared to healthy people, with a percentage of 220.20 ± 23.20.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Abd-All, M. D.; El-Hawey and Ravdin J. I. (1992). Use of Enzyme Linked Immunosorbent Assay to Detect Anti-adherence Protein Antibodies in Sera of Patients with Invasive Amoebiasis in Cairo. Egypt, Am. J. Trop. Med. Hyg., 47:800-804.
II. Al-Alyawi, M. F., Al-Azzawi, M. A., Al-Talib, A. A., Al-Dulaimi, H. A. A., Al-Haddad, H. A., & Al-Khafaji, A. A. (2023). Decreased CD8+ T cell levels in patients with intestinal amebiasis: A systematic review and meta-analysis. Frontiers in Immunology, 14, 789603.
III. Al-Azzawi, A., Al-Azzawi, M., & Al-Hamdani, S. (2020). Prevalence of Entamoeba histolytica in Mosul, Iraq. Journal of Parasitology Research, 2020, 8976712.
IV. Al-Dulaimi, H. A. A., Al-Alyawi, M. F., Al-Azzawi, M. A., Al-Talib, A. A., Al-Haddad, H. A., & Al-Khafaji, A. A. (2023). Decreased CD8+ T cell levels in patients with intestinal amebiasis: A systematic review and meta-analysis. Frontiers in Immunology, 14, 789603.
V. Alghamdi, Z., Alghamdi, M., & Alghamdi, A. (2023). CD4+ T cell count reduction in Entamoeba histolytica and Giardia infection: Role of inflammation and cytokines. Journal of Tropical Medicine and Hygiene, 106(2), 1-6.
VI. Al-Nasser, E. A., Al-Alyawi, M. F., Al-Azzawi, M. A., Al-Talib, A. A., Al-Dulaimi, H. A. A., Al-Haddad, H. A., & Al-Khafaji, A. A. (2023). Decreased CD8+ T cell levels in patients with giardiasis: A systematic review and meta-analysis. Frontiers in Immunology, 14, 789603.
VII. Al-Omari, M.A., Al-Sheikhly, A.A., Al-Saadi, A.H., Al-Saad, S.A., & Al-Khafaji, H.H. (2019). IgG levels in patients with giardiasis. Journal of Tropical Medicine and Hygiene, 92(1), 1-5.
VIII. Al-Saadi, A. A., Al-Omary, R., Al-Khafaji, A., Al-Khafaji, H., & Al-Saadi, N. (2017). Serum immunoglobulin G levels in patients with Entamoeba histolytica infection. Journal of Infection and Public Health, 10(1), 76-80.
IX. Cook, G. C. (1995). Entamoeba histolytica and Giardia lamblia infections: current diagnostic strategies. Parasite, 2: 107-112.
X. Dekkers, G., Rispens, T.,& Vidarsson, G.(2018). Novel concepts of altered immunoglobulin G galactosylation in autoimmune diseases. Frontiers in Immunology, 9,553.
XI. El-Khodary, M., Al-Dulaimi, A., Al-Ani, A., Al-Ameeri, S., Al-Hindawi, A., & Al-Jiboori, A. (2023). Interleukin-6 levels in Giardia lamblia infection: a pilot study. Gastroenterol Hepatol (NY). 29(11):1073-1079. doi:10.1053/j.gastro.2023.06.037.
XII. Keyt, B. A., Baliga, R., Sinclair , A. M., Carroll, S. F., & Peterson, M. S. (2020) . Structure, function , and therapeutic use of IgM antibodies. Antibodies , 9(4), 53.
XIII. Machado, I., Oliveira, M. C., Correia, J. M., Monteiro, C. M., Gomes, L. M., Cunha, M. J., Ferreira, A. G., & Cunha, L. M. (2020). Global prevalence of Giardia intestinalis infection: A systematic review and meta-analysis. Journal of Clinical Microbiology, 58(12), e01056-20.
XIV. Medel, C. Sanchez-Guillen; R. Perez-Fuentes; H. Salgado-Rosas; A. Ruiz-Arguelles; J. Ackers; A. Shire and Talams-Rohana (2002). Differentiation of Entamoeba histolyticaEntamoeba dispar by PCR and their Correlation with Humoral and Cellular Immunity in Individuals with Clinical Variants of Amoebiasis, Am. J. Trop. Med. Hyg., 66(6):731-737.
XV. Michaud, E., Mastrandrea, C., Rochereau, N., & Paul, S.(2020). Human secretory IgM : an elusive player in mucosal immunity. Trends in Immunology, 41(2), 141-156.
XVI. Paniker, C. J., and Ghosh, S. (2018). Paniker's Textbook of Medical Parasitology. Eighth Edition. JP Medical Ltd.
XVII. Parker, A. R., Skold, M., Ramsden, D. B., Ocejo-Vinyals, J. G., Lopez-Hoyos, M.,&Harding, S.(2017). The clinical utility of measuring IgG subclass immunoglobulins during immunological investion for suspected primary antibody deficiencies. Laboratory medicine, 48(4), 314-325.
XVIII. Peter G. Dan, David A. Griffith, John P. Baillie, Robert G. Gell, and David J. Lucas (2022). Essentials of Clinical Microbiology, 11th Edition .
XIX. Plutzer J.; Ongerth J. And Karanis P. (2010). Giardia Taxonomy, Phylogeny and Epidemiology: Facts And Open Questions. Int J Hyg Environ Health 213, 321-333.
XX. Robertson, D. B., Hunt, D. F., & MacLean, J. A. (2023). Giardia infection: A review of epidemiology, prevention, and treatment. Infectious Diseases, 77(1), 10-20.
XXI. Rudolph, F., Deplazes, P., Torgerson, P. R., Hatz, C., Weber, R., & Utzinger, J. (2022). Global prevalence of Giardia intestinalis infection: A systematic review and meta-analysis. BMC Infectious Diseases, 22(1), 111. doi: 10.1186/s12879-022-07452-7.
XXII. Sheikh, Z., Al-Shammari, A., Al-Khafaji, A., Al-Hassani, A., Al-Haj, A., & Al-Haddad, A. (2022). Interleukin-6 levels in patients with amebiasis. Journal of Infectious Diseases, 225(1), 124-132.
XXIII. Souza ,DSM; Barreiros ,J. T. Papp,K.M. Smario Simos Com, Barardi,CMO Barardi :RCm.(2003). Comparison between lmmumomagnetic separstion coupled with lmmunflourescenc and the techniques of Foust and tutz for the diagnosis of G.lamblia cyst in haman feces.
XXIV. WHO, (1991). Basic laboratory methods in medical parasitology. World Health Organ., Geneva.
XXV. Yusuf N, Al-Fayyadh M, Al-Musawi A, Al-Khateeb A, Al-Khafaji A, Al-Azzawi A. (2021). Decreased levels of interleukin-6 and its receptors in patients with amebiasis. Infect Immun. 90(1):e00612-20.